Healthcare professionals are required to complete training before prescribing Tolvaptan. Please follow the link to access the Tolvaptan Teva Training For Healthcare Professionals and to register your completion of this training. These materials provide important safety information on the risks of Tolvaptan Teva treatment, including liver toxicity, pregnancy prevention, monitoring requirements, dose and method of administration information, as well as the process for reporting adverse events. This training does not replace the Summary of Product Characteristics (SmPC), which should be read thoroughly before prescribing or dispensing Tolvaptan Teva. Patients should also be advised to read the Patient Information Leaflet (PIL).